Profusa, Inc.

Profusa, Inc. (Nasdaq: PFSA) is a medical technology company developing tissue-integrated injectable biosensors for continuous, real-time monitoring of body chemistry, placing it in the digital health and medical devices sector. Currently operating as a publicly traded company, Profusa filed a Form 10-Q with the SEC on May 15, 2026, under accession number 0001213900-26-057887, providing its latest quarterly financial and operational update. The company's platform targets both clinical and consumer health applications, with sensors designed to measure key physiological biomarkers on a continuous basis. To access Profusa's full filing history, SPAC deal data, and platform analytics, sign up at SpacDesk.